Low-dose naltrexone use for the management of post-acute sequelae of COVID-19-Reference-Cited by-同舟云学术

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19

Published:2023-11 Issue: Volume:124 Page:110966
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Bonilla Hector^ORCID,Tian Lu,Marconi Vincent C.,Shafer Robert,McComsey Grace A.^ORCID,Miglis Mitchel,Yang Philip,Bonilla Andres,Eggert Lauren^ORCID,Geng Linda N.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference30 articles.

1. NIH, COVID-19 Treatment Guidelines, April, 20 2023; https://www.covid19treatmentguidelines.nih.gov/.

2. NIH, RECOVER: Researching COVID to Enhance Recovery. April, 23 2023; https://recovercovid.org.

3. Clues to long COVID;Couzin-Frankel;Science,2022

4. Unexplained post-acute infection syndromes;Choutka;Nat. Med.,2022

5. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial;Bruun;Trials,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A practical framework for Long COVID treatment in primary care;Life Sciences;2024-10

2. Long COVID: current management and future prospects;COVID-19: An Update;2024-09-01

3. Human herpesvirus reactivation and its potential role in the pathogenesis of post-acute sequelae of SARS-CoV-2 infection;GeroScience;2024-08-29

4. Long COVID management: a mini review of current recommendations and underutilized modalities;Frontiers in Medicine;2024-06-14

5. Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia;BMJ Open;2024-05